masoprocol has been researched along with Acute Lymphoid Leukemia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dächert, J; Fulda, S; Probst, L; Schenk, B | 1 |
1 other study(ies) available for masoprocol and Acute Lymphoid Leukemia
| Article | Year |
|---|---|
Lipoxygenase inhibitors protect acute lymphoblastic leukemia cells from ferroptotic cell death.
Topics: alpha-Tocopherol; Antineoplastic Agents; Antioxidants; Arachidonate 12-Lipoxygenase; Arachidonate 15-Lipoxygenase; Carbolines; Cell Death; Cell Line, Tumor; Cyclohexylamines; Fas-Associated Death Domain Protein; Flavanones; Gene Expression Regulation, Neoplastic; Glutathione Peroxidase; Humans; Kinetics; Lipid Peroxidation; Lipoxygenase Inhibitors; Masoprocol; Neoplasm Proteins; Oxidative Stress; Phenylenediamines; Phospholipid Hydroperoxide Glutathione Peroxidase; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Reactive Oxygen Species | 2017 |